2002
DOI: 10.1016/s0306-4522(01)00587-5
|View full text |Cite
|
Sign up to set email alerts
|

Interaction between neuropeptide FF and opioids in the ventral tegmental area in the behavioral response to novelty

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

2005
2005
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 28 publications
(13 citation statements)
references
References 59 publications
0
13
0
Order By: Relevance
“…For example, infusion of the antiopioid peptide, neuropeptide FF, into the VTA reduced locomotor response to novelty, whereas an inhibitor of enkephalin degradation strongly increased novelty-induced locomotion (Cador et al, 2002). Moreover, it has been shown that chronic cocaine treatment increases m-opioid receptor density in dopaminergic projection regions both in rats (Hammer, 1989;Unterwald et al, 1992) and human cocaine addicts (Zubieta et al, 1996), indicating that dopaminergic and opioid systems have reciprocal interaction with regard to their reinforcing effects.…”
Section: Discussionmentioning
confidence: 99%
“…For example, infusion of the antiopioid peptide, neuropeptide FF, into the VTA reduced locomotor response to novelty, whereas an inhibitor of enkephalin degradation strongly increased novelty-induced locomotion (Cador et al, 2002). Moreover, it has been shown that chronic cocaine treatment increases m-opioid receptor density in dopaminergic projection regions both in rats (Hammer, 1989;Unterwald et al, 1992) and human cocaine addicts (Zubieta et al, 1996), indicating that dopaminergic and opioid systems have reciprocal interaction with regard to their reinforcing effects.…”
Section: Discussionmentioning
confidence: 99%
“…For feeding experiments, drug concentrations for met-enkephalin (0.025, 0.25, 2.5 nmoles/NAcc) and the enkephalin analogue DALA (0.025, 0.25, 2.5, 12.5 nmoles/NAcc) were chosen to bracket a dose of DAMGO that elicits robust feeding (0.25 nanomoles/NAcc). Thiorphan doses (4, 13, 40 nmoles/NAcc) were guided by previous reports that concentrations as low as 1–10 nmoles were sufficient to elicit significant behavioral effects (Kalivas and Richardson-Carlson, 1986, Cador et al, 2002). Finally, the DPDPE dose (4 nmoles/NAcc) was chosen to match the concentration identified in a previous report as the dose maximally effective in eliciting food intake when infused into the NAcc (Bakshi and Kelley, 1993a).…”
Section: Methodsmentioning
confidence: 99%
“…There is evidence that a novel or surprising stimulus can evoke unconditioned responses through the release of endogenous opioids, including analgesia, and that the reduction in these responses across exposures to the stimulus is blocked by naloxone (eg, Cador et al, 2002;Foo and Westbrook, 1991;Hernandez and Watson, 1997;Izquierdo et al, 1984;Rochford and Dawes, 1993). Accordingly, naloxone disrupted the error signal, which normally drives the formation of the inhibitory association in latent inhibition.…”
Section: Discussionmentioning
confidence: 99%